Nippon Shinyaku Co.,Ltd. (4516) Cash flow
Market cap
¥357.7B
P/E ratio
13.1x
Nippon Shinyaku manufactures and sells pharmaceuticals and functional foods through six subsidiaries operating in Japan, the US, and China.
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 2,665 | 2,452 | 2,648 | 2,773 | 3,418 | 3,468 | 3,550 | 4,588 | 5,041 | 5,023 | 6,015 |
| Cash from operations | 6,113 | 8,915 | 18,916 | 6,719 | 15,310 | 12,737 | 21,388 | 21,316 | 26,170 | 16,289 | 36,126 |
| Capital expenditures | -1,156 | -1,517 | -4,131 | -4,017 | -1,351 | -1,817 | -2,168 | -3,137 | -5,660 | -5,058 | -3,352 |
| Cash from investing | -3,718 | -3,978 | -5,750 | -11,342 | 511 | -2,339 | -1,564 | -10,037 | -17,631 | -9,921 | -28,877 |
| Payments for dividends | -1,618 | -1,819 | -2,154 | -3,768 | -3,698 | -5,651 | -6,196 | -6,799 | -7,809 | -8,011 | -8,348 |
| Repurchases of common stock | -152 | -85 | -36 | -14 | -5 | -3 | -3 | -2 | -1 | - | -1 |
| Cash from financing | -1,773 | -1,907 | -2,193 | -3,787 | -3,708 | -5,660 | -6,199 | -8,407 | -9,605 | -9,719 | -9,902 |
| Free cash flow | |||||||||||
| FCF margin (%) |